FMS (FMS) Stock Price & Analysis
FMS (FMS) rose 0.61% to USD 24.59 as of July 25, 2026 at 03:04 UTC, according to Nexqual real-time market data.
FMS last closed at USD 24.44; the session ranged USD 24.39–24.7 on volume of 566,903 shares. Market capitalization is $13.21B, with a 52-week range of USD 20.02–27.64 (NYQ). Source: Nexqual, July 25, 2026 at 03:04 UTC.
Key Statistics (as of July 25, 2026 at 03:04 UTC)
| Price | USD 24.59 |
|---|---|
| Change | ▲ 0.61% (up) |
| Previous Close | USD 24.44 |
| Open | USD 24.46 |
| Day Range | USD 24.39 – 24.7 |
| 52-Week Range | USD 20.02 – 27.64 |
| Volume | 566,903 shares |
| Market Cap | $13.21B |
| Exchange | NYQ |
Technical Analysis (FMS)
Nexqual's technical model rates FMS "BUY" based on 5 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 03:04 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 65.44 (neutral) |
| vs SMA50 | Above (USD 22.92) |
| MACD | 0.42 (positive) |
Analyst Ratings (FMS)
Wall Street analysts rate FMS "Hold" based on 7 analysts, with a mean price target of USD 25.58 (range USD 18.09–37.83), per Nexqual as of July 25, 2026 at 03:04 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 7 |
| Mean Target | USD 25.58 |
| High Target | USD 37.83 |
| Low Target | USD 18.09 |
| Buy / Hold / Sell | 2 / 3 / 2 |
Earnings (FMS)
| Next Earnings Date | 2026-08-04 |
|---|---|
| EPS Estimate | USD 0.5 |
| Revenue Estimate | $4.78B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.46 vs est 0.5 ▼ miss |
| 2025-12-31 | USD 0.72 vs est 0.55 ▲ beat |
| 2025-09-30 | USD 0.55 vs est 0.5 ▲ beat |
| 2025-06-30 | USD 0.46 vs est 0.47 ▼ miss |
Source: Nexqual, July 25, 2026 at 03:04 UTC.
Financials & Fundamentals (FMS)
| Total Revenue | $19.36B |
|---|---|
| Revenue Growth (YoY) | -5.50% |
| Gross Margin | +25.96% |
| Operating Margin | +8.14% |
| Profit Margin | +4.88% |
| ROE | +7.85% |
| Debt / Equity | 77.75 |
| Current Ratio | 1.21 |
| Total Cash | $1.24B |
| Total Debt | $11.04B |
| Free Cash Flow | $1.67B |
Source: Nexqual, July 25, 2026 at 03:04 UTC.
Financial Health Score (FMS)
Nexqual rates FMS's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 03:04 UTC.
| Growth | Mixed — Revenue +1.5% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 26%, operating 8% |
| Balance Sheet | Mixed — $1.24B cash vs $11.0B debt |
| Cash Flow | Solid — FCF $1.67B, 9% margin |
| Efficiency | Mixed — ROE 8%, ROA 3.6% |
Ownership (FMS)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +9.69% |
| Shares Outstanding | 537.13M |
| Float | 367.51M |
Source: Nexqual, July 25, 2026 at 03:04 UTC.
Leadership (FMS)
FMS is led by Helen Giza (age 57), Chair of Management Board & CEO, per Nexqual as of July 25, 2026 at 03:04 UTC.
| Chair of Management Board & CEO | Helen Giza (age 57) |
|---|---|
| CFO & Member of the Management Board | Martin Fischer (age 48) |
| Member of the Management Board, Global Head of Legal,Compliance & Human Resources and Labor Director | Jorg Haring (age 55) |
| Senior Vice President of Corporate Communications & Governmental Affairs | Joachim Weith |
| Senior Vice President of Research & Development | Gail-Suzanne Brown |
Major Backers & Investors (FMS)
Notable institutional backers of FMS include Pzena Investment Management LLC, Dodge & Cox Inc., Fiduciary Management, Inc., according to Nexqual as of July 25, 2026 at 03:04 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Pzena Investment Management LLC | 3.07% |
| Dodge & Cox Inc. | 1.56% |
| Fiduciary Management, Inc. | 0.91% |
| Morgan Stanley | 0.51% |
| Millennium Management | 0.33% |
| Brandes Investment Partners L.P. | 0.33% |
| Todd Asset Management LLC | 0.26% |
| FMI Funds Inc-Large Cap Fund | 0.25% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.19% |
Source: Nexqual, July 25, 2026 at 03:04 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SNN | Smith & Nephew SNATS, Inc. | USD 30.57 | ▲ 2.1% |
| DVA | DaVita Inc. | USD 235.44 | ▲ 1.45% |
| UHS | Universal Health Services, Inc. | USD 155.75 | ▲ 4.29% |
| GRFS | Grifols, S.A. | USD 7.58 | ▼ 3.81% |
| MD | Pediatrix Medical Group, Inc. | USD 26.26 | ▲ 1.66% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:04 UTC. This page is informational and not investment advice.